MetaCap

Ascendis Pharma A/S Statistics

NASDAQ: ASNDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

252.73-3.23 (-1.26%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ascendis Pharma A/S by the numbers

Ascendis Pharma A/S has a market capitalization of $16.58 billion based on 65.60M shares outstanding. Its trailing P/E ratio is 16.6, below the 4-company peer median of 31.2, and its forward P/E is 20.5. The stock trades 4.2% above its 50-day average and 4.9% above its 200-day average.

Average daily trading volume is 750.65K shares, or about $189.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ASND valuation vs. peer median

ASND compared with the median of 8 peer companies
MetricASNDPeer medianDifference
Market cap$16.58B$14.80B+12%
P/E (TTM)16.631.2-47%
Forward P/E20.514.5+41%
Avg. volume750.65K2.51M-70%

Peer median across 8 companies: BBIO, JAZZ, ALNY, ELAN, RDY, BMRN, VTRS, UTHR.

Valuation

Price and trading

Previous close
255.96
Open
255.44
Day range
251.55 – 256.50
52-week range
188.08 – 282.15
52-week change
+20.07%
Beta
—
Volume
602.89K

Dividends and events

Annual dividend
None
Next earnings date
Apr 30, 2026

Additional statistics

Market Cap
16.58B
Pe
16.62
Forward Pe
20.47
Eps
15.21
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
282.15
Week52 Low
188.08
Avg Volume
750.65K
Shares Outstanding
65.60M
Ma50
242.58
Ma200
240.90
Earnings Date
Apr 30, 2026
Pct From52w High
-10.43%
Pct From52w Low
34.37%

Related